Vinorelbine as first-line or second-line therapy for advanced breast cancer: a Phase I-II trial by the Danish Breast Cancer Co-operative Group

Autor: Langkjer, Sven T, Ejlertsen, Bent, Mouridsen, Henning, Andersen, Jørn, Nielsen, Mette Møller, Møller, Knud Age, Madsen, Ebbe Lindegaard, Haarh, Vera, Danish, Breast Cancer Co-operative Group

Publikováno v: Langkjer, S T, Ejlertsen, B, Mouridsen, H, Andersen, J, Nielsen, M M, Møller, K A, Madsen, E L, Haarh, V & Danish Breast Cancer Co-operative Group 2008, ' Vinorelbine as first-line or second-line therapy for advanced breast cancer: a Phase I-II trial by the Danish Breast Cancer Co-operative Group ', Acta Oncologica, vol. 47, no. 4, pp. 735-9 . https://doi.org/10.1080/02841860801971421
Langkjer, S T, Ejlertsen, B, Mouridsen, H, Andersen, J, Nielsen, M M, Møller, K A, Madsen, E L, Haarh, V & Danish, B C C G 2008, ' Vinorelbine as first-line or second-line therapy for advanced breast cancer : a Phase I-II trial by the Danish Breast Cancer Co-operative Group ', Acta Oncologica, vol. 47, no. 4, pp. 735-739 . https://doi.org/10.1080/02841860801971421

Udgivelsesdato: 2008-null INTRODUCTION: This study was conducted to establish the maximum tolerated dose (MTD) of intravenous vinorelbine and on the determined dose to assess efficacy and safety in patients with metastatic breast cancer previously tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76659bd1213cb6963156cac100e166ab
https://pure.au.dk/portal/da/publications/vinorelbine-as-firstline-or-secondline-therapy-for-advanced-breast-cancer-a-phase-iii-trial-by-the-danish-breast-cancer-cooperative-group(112243b0-0706-11de-8317-000ea68e967b).html